Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Board appointment

10 Jan 2023 07:00

RNS Number : 1607M
Curtis Banks Group PLC
10 January 2023
 

10 January 2023

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION NO 596/2014 (INCORPORATED INTO UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED BY VIRTUE OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

Curtis Banks Group plc

 

("Curtis Banks", "the Group" or "the Company")

 

Board appointment

 

Curtis Banks, one the U.K.'s leading SIPP providers, today announces the appointment of Peter Docherty as Interim Chief Executive Officer and an Executive Director of the Group with immediate effect, pending regulatory approval.

 

The appointment of Peter will result in David Barral reverting to the role of Non-Executive Chairman with effect from 1 February 2023, having fulfilled the role of Executive Chairman since August 2022.

 

Peter has over 20 years of experience in financial services, having most recently been the Chief Executive and Managing Director of the Embark Platform during which time he led a significant increase in customers and assets under administration driven by organic growth and integration initiatives. Previous positions include the roles of Chief Executive Officer and Chief Risk Officer of Alliance Trust Savings Limited.

 

David Barral, Chairman of Curtis Banks, commented: "Peter is a highly capable senior executive with an impressive track record in leadership, transformation, operations and delivering results. He joins us at an exciting time as we work towards the completion of the acquisition by Nucleus. Having an experienced CEO at the helm is an important step in strengthening our leadership team and allows me to step back into my role as Non-Executive Chairman."

Peter Docherty, Interim CEO, commented: "I am excited to join Curtis Banks at this critical juncture for the Company and following the announcement of the proposed acquisition by Nucleus. Curtis Banks has been at the forefront of retirement solutions in the UK wealth market and has the capabilities, competitive position and talent to build momentum and capitalise on the opportunities that exist in its core market segments. I am delighted to lead the business through the next stage of its growth journey."

 

AIM disclosures:

 

The following information regarding the appointment of Peter Gordon John Docherty, aged 41, is disclosed under Schedule 2(g) of the AIM Rules for Companies.

 

Current directorships and/or partnerships:

ELT Recycling Limited

 

 

Former directorships and/or partnerships (within the last five years):

Alliance Trust Savings Limited

Embark Investment Services Limited

Investor Nominees (Dundee) Limited (previously Alliance Trust Savings Nominees Limited)

 

Peter Docherty does not have any beneficial interest in the ordinary shares of the Company.

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

 

 

 

 

For more information, please contact:

 

Curtis Banks Group plc via Instinctif Partners

David Barral - Executive Chairman

Dan Cowland - Chief Financial Officer

 

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0) 20 7418 8900

Andrew Buchanan

James Steel

 

 

Singer Capital Markets Limited (Joint Broker) +44 (0) 20 7496 3000

Rick Thompson

James Moat

 

 

Instinctif Partners (investor relations adviser to Curtis Banks) curtisbanks@instinctif.com

Tim Linacre +44 (0) 20 7457 2020

Victoria Hayns

Joe Quinlan

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGGMLLZGFZM
Date   Source Headline
1st Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSHolding(s) in Company
21st Oct 20212:48 pmRNSHolding(s) in Company
20th Oct 20213:08 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSDirector/PDMR Dealing
11th Oct 20219:38 amRNSDirector/PDMR Dealing
22nd Sep 20211:00 pmRNSDividend Timetable
9th Sep 20217:00 amRNSInterim Results
1st Sep 20214:35 pmRNSTR-1: Notification of major holdings
19th Jul 20217:00 amRNSTrading Update
25th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 20217:00 amRNSTR1: Notification of Major Holdings
8th Jun 20212:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20212:03 pmRNSDirector/PDMR Shareholding
27th May 20214:40 pmRNSResult of AGM
12th May 20215:11 pmRNSCorrection to Notice of Annual General Meeting
30th Apr 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20217:00 amRNSDirector/PDMR Shareholding
19th Apr 20214:24 pmRNSDirector/PDMR Shareholding
12th Apr 20215:37 pmRNSDirector/PDMR Shareholding
8th Apr 20215:59 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
5th Feb 202110:12 amRNSHolding(s) in Company
19th Jan 20217:00 amRNSAppointment of Non-Executive Director
12th Jan 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
30th Nov 20207:00 amRNSTrading and Operations Update
26th Nov 20204:49 pmRNSHolding(s) in Company
13th Nov 20204:33 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
28th Oct 202010:00 amRNSDirector/PDMR Shareholding
6th Oct 20207:00 amRNSCompletion of acquisition of Talbot and Muir
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSLong-Term Incentive Plan
7th Sep 20207:01 amRNSInvestor Presentation
7th Sep 20207:00 amRNSDividend timetable
3rd Sep 20207:00 amRNSInterim Results
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSNotice of Results
30th Jul 202012:26 pmRNSHolding(s) in Company
28th Jul 20209:20 amRNSHolding(s) in Company
27th Jul 20206:14 pmRNSHolding(s) in Company
23rd Jul 20202:20 pmRNSResult of placing
23rd Jul 20207:27 amRNSProposed Placing to raise £25m
23rd Jul 20207:25 amRNSAcquisition of Talbot and Muir and Dunstan Thomas
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.